Rhinovirus and the developing lung

Paediatric Respiratory Reviews

Volumn 15, Issue 3, 2014, Pages 268-274

  Cox, D W ^a,b   Le Souef P N ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

Children; Respiratory illnesses; Rhinovirus

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN E ANTIBODY;

ACUTE RESPIRATORY TRACT DISEASE; ASTHMA; ATOPY; CHILD; CHILDHOOD; DISEASE ASSOCIATION; HUMAN; HUMAN RHINOVIRUS; HUMAN RHINOVIRUS A; HUMAN RHINOVIRUS C; LUNG DEVELOPMENT; LUNG FUNCTION; NONHUMAN; ONSET AGE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RHINOVIRUS INFECTION; SPECIES COMPARISON; VIRAL BRONCHIOLITIS; VIRUS DETECTION; VIRUS VIRULENCE; BRONCHIOLITIS; CLASSIFICATION; COMMON COLD; COMPLICATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; INFANT; LUNG; PATHOPHYSIOLOGY; PHENOTYPE; PRESCHOOL CHILD; RHINOVIRUS;

BRONCHIOLITIS; CHILD; CHILD, PRESCHOOL; COMMON COLD; HUMANS; INFANT; LUNG; PHENOTYPE; RHINOVIRUS;

EID: 84906517160     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2014.03.002     Document Type: Review

References (114)

1. Price W.H. The Isolation of a New Virus Associated with Respiratory Clinical Disease in Humans. Proc Natl Acad Sci U S A 1956, 42(12):892-896.
2. Nicholson K.G., Kent J., Ireland D.C. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993, 307(6910):982-986.
3. Johnston S.L., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995, 310(6989):1225-1229.
4. Monto A.S. Epidemiology of viral respiratory infections. Am J Med 2002, 112 Suppl 6A:4S-12S.
5. Lee W.M., et al. Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med 2012, 186(9):886-891.
6. Papadopoulos N.G., et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med 2002, 165(9):1285-1289.
7. Juven T., et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000, 19(4):293-298.
8. Choi E.H., et al. The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005. Clin Infect Dis 2006, 43(5):585-592.
9. Chantzi F.M., et al. Human rhinoviruses in otitis media with effusion. Pediatr Allergy Immunol 2006, 17(7):514-518.
10. Huang T., et al. Evidence of recombination and genetic diversity in human rhinoviruses in children with acute respiratory infection. PLoS One 2009, 4(7):e6355.
11. Ledford R.M., et al. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. J Virol 2004, 78(7):3663-3674.
12. Greve J.M., et al. The major human rhinovirus receptor is ICAM-1. Cell 1989, 56(5):839-847.
13. Uncapher C.R., DeWitt C.M., Colonno R.J. The major and minor group receptor families contain all but one human rhinovirus serotype. Virology 1991, 180(2):814-817.
14. Hofer F., et al. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc Natl Acad Sci U S A 1994, 91(5):1839-1842.
15. Vlasak M., Goesler I., Blaas D. Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment. J Virol 2005, 79(10):5963-5970.
16. Lamson D., et al. MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004-2005. J Infect Dis 2006, 194(10):1398-1402.
17. Arden K.E., et al. Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections. J Med Virol 2006, 78(9):1232-1240.
18. Palmenberg A.C., Rathe J.A., Liggett S.B. Analysis of the complete genome sequences of human rhinovirus. J Allergy Clin Immunol 2010, 125(6):1190-1199. quiz 1200-1.
19. Palmenberg A.C., et al. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 2009, 324(5923):55-59.
20. Mackay I.M., et al. Prior evidence of putative novel rhinovirus species. Australia. Emerg Infect Dis 2008, 14(11):1823-1824. author reply 1824-5.
21. Linder J.E., et al. Human rhinovirus C: Age, season, and lower respiratory illness over the past 3 decades. J Allergy Clin Immunol 2013, 131(1). p. 69-77 e1-6.
22. Bizzintino J., et al. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J 2011, 37(5):1037-1042.
23. Miller E.K., et al. Human rhinovirus C associated with wheezing in hospitalised children in the Middle East. J Clin Virol 2009, 46(1):85-89.
24. Lau S.K., et al. Clinical and molecular epidemiology of human rhinovirus C in children and adults in Hong Kong reveals a possible distinct human rhinovirus C subgroup. J Infect Dis 2009, 200(7):1096-1103.
25. Nokso-Koivisto J., et al. Human picornavirus and coronavirus RNA in nasopharynx of children without concurrent respiratory symptoms. J Med Virol 2002, 66(3):417-420.
26. Jartti T., et al. Identification of respiratory viruses in asymptomatic subjects: asymptomatic respiratory viral infections. Pediatr Infect Dis J 2008, 27(12):1103-1107.
27. van der Zalm M.M., et al. Respiratory Pathogens in Children with and without Respiratory Symptoms. Journal of Pediatrics 2009, 154(3):396-400.
28. Killington R.A., Stott E.J., Lee D. The effect of temperature on the synthesis of rhinovirus type 2 RNA. J Gen Virol 1977, 36(3):403-411.
29. Papadopoulos N.G., et al. Rhinoviruses replicate effectively at lower airway temperatures. J Med Virol 1999, 58(1):100-104.
30. Gern J.E., et al. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997, 155(3):1159-1161.
31. Papadopoulos N.G., et al. Rhinoviruses infect the lower airways. J Infect Dis 2000, 181(6):1875-1884.
32. Jartti T., et al. Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol 2004, 72(4):695-699.
33. Kling S., et al. Persistence of rhinovirus RNA after asthma exacerbation in children. Clin Exp Allergy 2005, 35(5):672-678.
34. Winther B., Hayden F.G., Hendley J.O. Picornavirus infections in children diagnosed by RT-PCR during longitudinal surveillance with weekly sampling: Association with symptomatic illness and effect of season. J Med Virol 2006, 78(5):644-650.
35. Jartti T., et al. Serial viral infections in infants with recurrent respiratory illnesses. Eur Respir J 2008, 32(2):314-320.
36. Olenec J.P., et al. Weekly monitoring of children with asthma for infections and illness during common cold seasons. J Allergy Clin Immunol 2010, 125(5). p. 1001-1006 e1.
37. Wainwright C. Acute viral bronchiolitis in children- a very common condition with few therapeutic options. Paediatr Respir Rev 2010, 11(1):39-45. quiz 45.
38. Hall C.B. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001, 344(25):1917-1928.
39. Kusel M.M., et al. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J 2006, 25(8):680-686.
40. Mansbach J.M., et al. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med 2008, 15(2):111-118.
41. Calvo C., et al. Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study. Acta Paediatr 2010, 99(6):883-887.
42. Mansbach J.M., et al. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med 2012, 166(8):700-706.
43. Rakes G.P., et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med 1999, 159(3):785-790.
44. Malmstrom K., et al. Human rhinovirus in bronchial epithelium of infants with recurrent respiratory symptoms. J Allergy Clin Immunol 2006, 118(3):591-596.
45. Minor T.E., et al. Viruses as precipitants of asthmatic attacks in children. JAMA: the journal of the American Medical Association 1974, 227(3):292-298.
46. Friedlander S.L., Busse W.W. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol 2005, 116(2):267-273.
47. Gern J.E. Rhinovirus respiratory infections and asthma. Am J Med 2002, 112 Suppl 6A:19S-27S.
48. Gern J.E., Busse W.W. Relationship of viral infections to wheezing illnesses and asthma. Nat Rev Immunol 2002, 2(2):132-138.
49. Nicholson K.G., et al. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ 1997, 315(7115):1060-1064.
50. Henderson J., et al. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol 2005, 16(5):386-392.
51. Sigurs N., et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010, 65(12):1045-1052.
52. Stein R.T., et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999, 354(9178):541-545.
53. Midulla F., et al. Rhinovirus bronchiolitis and recurrent wheezing: 1-year follow-up. Eur Respir J 2012, 39(2):396-402.
54. Kusel M.M., et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007, 119(5):1105-1110.
55. Kusel M.M., et al. Febrile respiratory illnesses in infancy & atopy are risk factors for persistent asthma & wheeze. Eur Respir J 2011.
56. Kotaniemi-Syrjanen A., et al. Rhinovirus-induced wheezing in infancy--the first sign of childhood asthma?. J Allergy Clin Immunol 2003, 111(1):66-71.
57. Jackson D.J., et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008, 178(7):667-672.
58. Papadopoulos N.G., et al. Mechanisms of rhinovirus-induced asthma. Paediatr Respir Rev 2004, 5(3):255-260.
59. Leigh R., et al. Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. J Allergy Clin Immunol 2008, 121(5). p. 1238-1245 e4.
60. Jakiela B., et al. Basal cells of differentiated bronchial epithelium are more susceptible to rhinovirus infection. Am J Respir Cell Mol Biol 2008, 38(5):517-523.
61. Canonica G.W., et al. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol 1995, 107(1-3):99-102.
62. Papi A., Johnston S.L. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J Biol Chem 1999, 274(14):9707-9720.
63. Wark P.A., et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005, 201(6):937-947.
64. Contoli M., et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006, 12(9):1023-1026.
65. Message S.D., et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A 2008, 105(36):13562-13567.
66. Sears M.R., et al. The relative risks of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma. Clin Exp Allergy 1989, 19(4):419-424.
67. Peat J.K., Salome C.M., Woolcock A.J. Longitudinal changes in atopy during a 4-year period: relation to bronchial hyperresponsiveness and respiratory symptoms in a population sample of Australian schoolchildren. J Allergy Clin Immunol 1990, 85(1 Pt 1):65-74.
68. Sherrill D., et al. On early sensitization to allergens and development of respiratory symptoms. Clin Exp Allergy 1999, 29(7):905-911.
69. Oddy W.H., et al. The effects of respiratory infections, atopy, and breastfeeding on childhood asthma. Eur Respir J 2002, 19(5):899-905.
70. Illi S., et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006, 368(9537):763-770.
71. Murray C.S., et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006, 61(5):376-382.
72. Holt P.G., Upham J.W., Sly P.D. Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J Allergy Clin Immunol 2005, 116(1):16-24. quiz 25.
73. Jackson D.J., et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med 2012, 185(3):281-285.
74. Subrata L.S., et al. Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J Immunol 2009, 183(4):2793-2800.
75. Jartti T., et al. Systemic T-helper and T-regulatory cell type cytokine responses in rhinovirus vs. respiratory syncytial virus induced early wheezing: an observational study. Respir Res 2009, 10:85.
76. Turato G., et al. Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma. Am J Respir Crit Care Med 2008, 178(5):476-482.
77. Baraldo S., et al. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol 2012, 130(6):1307-1314.
78. Maas T., et al. Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthma. Cochrane Database Syst Rev 2009, (3):CD006480.
79. Phelan P.D., Robertson C.F., Olinsky A. The Melbourne Asthma Study: 1964-1999. J Allergy Clin Immunol 2002, 109(2):189-194.
80. Sears M.R., et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003, 349(15):1414-1422.
81. Stern D.A., et al. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 2007, 370(9589):758-764.
82. Goksor E., et al. Reduced airway function in early adulthood among subjects with wheezing disorder before two years of age. Pediatr Pulmonol 2008, 43(4):396-403.
83. Piippo-Savolainen E., et al. Early predictors for adult asthma and lung function abnormalities in infants hospitalized for bronchiolitis: a prospective 18- to 20-year follow-up. Allergy Asthma Proc 2006, 27(4):341-349.
84. Guilbert T.W., et al. Decreased lung function after preschool wheezing rhinovirus illnesses in children at risk to develop asthma. J Allergy Clin Immunol 2011, 128(3). p. 532-8 e1-10.
85. Young S., et al. Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis. Arch Dis Child 1995, 72(1):16-24.
86. Turner S.W., et al. Reduced lung function both before bronchiolitis and at 11 years. Arch Dis Child 2002, 87(5):417-420.
87. Cox D.W. e.a., Associations between bronchiolitis and respiratory outcomes at 18 years in the PIAF birth cohort. Eur Respir J 2011, 38(Suppl. 55):212s.
88. Dominguez S.R., et al. Multiplex MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade. J Clin Virol 2008, 43(2):219-222.
89. Briese T., et al. Global distribution of novel rhinovirus genotype. Emerg Infect Dis 2008, 14(6):944-947.
90. Xiang Z., et al. Human rhinovirus group C infection in children with lower respiratory tract infection. Emerg Infect Dis 2008, 14(10):1665-1667.
91. Linsuwanon P., et al. High prevalence of human rhinovirus C infection in Thai children with acute lower respiratory tract disease. J Infect 2009, 59(2):115-121.
92. Wisdom A., et al. Genetics, recombination and clinical features of human rhinovirus species C (HRV-C) infections; interactions of HRV-C with other respiratory viruses. PLoS One 2009, 4(12):e8518.
93. Jin Y., et al. Prevalence and clinical characterization of a newly identified human rhinovirus C species in children with acute respiratory tract infections. J Clin Microbiol 2009, 47(9):2895-2900.
94. Arden K.E., et al. Newly identified respiratory viruses in children with asthma exacerbation not requiring admission to hospital. J Med Virol 2010, 82(8):1458-1461.
95. Calvo C., et al. Role of rhinovirus C respiratory infections in sick and healthy children in Spain. Pediatr Infect Dis J 2010, 29(8):717-720.
96. Iwane M.K., et al. Human Rhinovirus Species Associated With Hospitalizations for Acute Respiratory Illness in Young US Children. J Infect Dis 2011, 204(11):1702-1710.
97. Miller E.K., et al. A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol 2009, 123(1). p. 98-104 e1.
98. Mak R.K., et al. Clinical spectrum of human rhinovirus infections in hospitalized Hong Kong children. Pediatr Infect Dis J 2011, 30(9):749-753.
99. Cox D.W., et al. HRV-C Infection in Young Children with Acute Wheeze is Associated with Increased Acute Respiratory Hospital Admissions. Am J Respir Crit Care Med 2013.
100. Linsuwanon P., et al. Complete coding sequence characterization and comparative analysis of the putative novel human rhinovirus (HRV) species C and B. Virol J 2011, 8:5.
101. Ashraf S., et al. Biological characteristics and propagation of human rhinovirus-C in differentiated sinus epithelial cells. Virology 2013, 436(1):143-149.
102. Smith M., et al. Corticosteroids for hospitalised children with acute asthma. Cochrane Database Syst Rev 2003, (2):CD002886.
103. Grant C.C., Duggan A.K., DeAngelis C. Independent parental administration of prednisone in acute asthma: a double-blind, placebo-controlled, crossover study. Pediatrics 1995, 96(2 Pt 1):224-229.
104. Horowitz L., et al. Acute asthma. Single dose oral steroids in paediatric community clinics. Eur J Pediatr 1994, 153(7):526-530.
105. Oommen A., Lambert P.C., Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet 2003, 362(9394):1433-1438.
106. Csonka P., et al. Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial. J Pediatr 2003, 143(6):725-730.
107. Jartti T., et al. Evaluation of the efficacy of prednisolone in early wheezing induced by rhinovirus or respiratory syncytial virus. Pediatr Infect Dis J 2006, 25(6):482-488.
108. Panickar J., et al. Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med 2009, 360(4):329-338.
109. Jartti T., et al. Efficacy of prednisolone in children hospitalized for recurrent wheezing. Pediatr Allergy Immunol 2007, 18(4):326-334.
110. Gustafson L.M., et al. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996, 97(4):1009-1014.
111. Papi A., et al. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor kappaB and c-Jun N-terminal kinase activation. J Allergy Clin Immunol 2013, 132(5). p. 1075-1085 e6.
112. Busse W.W., et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011, 364(11):1005-1015.
113. Charles C.H., et al. Prevention of human rhinovirus infection by multivalent fab molecules directed against ICAM-1. Antimicrob Agents Chemother 2003, 47(5):1503-1508.
114. Fang F., Yu M. Viral receptor blockage by multivalent recombinant antibody fusion proteins: inhibiting human rhinovirus (HRV) infection with CFY196. J Antimicrob Chemother 2004, 53(1):23-25.